SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IFLO is Breaking Out

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sergio H who wrote (899)3/28/2000 4:26:00 PM
From: James Strauss  Read Replies (1) of 1018
 
Sergio:

If the $35.00 net average profit for Painbuster and On-Q is correct, it would be hard for IFLO not to have an eps north of $9.00... We'll have to see what market share they currently have, and project forward... A 10% market share is reasonable to expect from a company that's setting a new standard for narcotic free pain medication delivery... I'd prefer that IFLO not be bought out at $15.00 or $20.00 for the quick buck... I think the stock would be worth much more if IFLO remains independent... What's your sense about this...

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext